{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:02:02Z","timestamp":1788494522762,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdcjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jdiacomp.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T04:48:29Z","timestamp":1510375709000},"page":"164-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study"],"prefix":"10.1016","volume":"32","author":[{"given":"Rasmus Bo","family":"Jansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas M\u00f8ller","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"B\u00fclow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"R\u00f8rdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per E.","family":"Holstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas Rye","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Lander","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdiacomp.2017.11.004_bb0005","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.2337\/dc09-1428","article-title":"Mortality associated with acute Charcot foot and neuropathic foot ulceration","volume":"33","author":"van Baal","year":"2010","journal-title":"Diabetes Care"},{"issue":"9347","key":"10.1016\/j.jdiacomp.2017.11.004_bb0010","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0140-6736(02)11671-0","article-title":"The Charcot foot","volume":"360","author":"Hartemann-Heurtier","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jdiacomp.2017.11.004_bb0015","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/diacare.23.6.796","article-title":"Long-term follow-up in diabetic Charcot feet with spontaneous onset","volume":"23","author":"Fabrin","year":"2000","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jdiacomp.2017.11.004_bb0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10016-003-0039-5","article-title":"Charcot joint disease in diabetes mellitus","volume":"17","author":"Lee","year":"2003","journal-title":"Ann Vasc Surg"},{"issue":"5","key":"10.1016\/j.jdiacomp.2017.11.004_bb0025","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.mcna.2013.04.003","article-title":"The charcot foot","volume":"97","author":"Rogers","year":"2013","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jdiacomp.2017.11.004_bb0030","doi-asserted-by":"crossref","DOI":"10.3402\/dfa.v2i0.6418","article-title":"An overview of conservative treatment options for diabetic Charcot foot neuroarthropathy","volume":"2","author":"Ramanujam","year":"2011","journal-title":"Diabet Foot Ankle"},{"issue":"1","key":"10.1016\/j.jdiacomp.2017.11.004_bb0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1757-1146-6-30","article-title":"Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot neuro-arthropathy: a systematic review","volume":"6","author":"Milne","year":"2013","journal-title":"J Foot Ankle Res"},{"issue":"6","key":"10.1016\/j.jdiacomp.2017.11.004_bb0040","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1464-5491.2005.01510.x","article-title":"Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between type 1 and type 2 diabetes","volume":"22","author":"Petrova","year":"2005","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.jdiacomp.2017.11.004_bb0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1475-097X.2009.00915.x","article-title":"Bone mineral density in diabetes mellitus patients with and without a Charcot foot","volume":"30","author":"Christensen","year":"2010","journal-title":"Clin Physiol Funct Imaging"},{"issue":"11","key":"10.1016\/j.jdiacomp.2017.11.004_bb0050","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2522\/ptj.20080025","article-title":"Inflammatory osteolysis in diabetic neuropathic (charcot) arthropathies of the foot","volume":"88","author":"Sinacore","year":"2008","journal-title":"Phys Ther"},{"issue":"suppl 1","key":"10.1016\/j.jdiacomp.2017.11.004_bb0055","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1002\/dmrr.846","article-title":"Charcot neuro-osteoarthropathy-current standards","volume":"24","author":"Petrova","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jdiacomp.2017.11.004_bb0060","article-title":"Novel use of a Dektak 150 surface profiler unmasks differences in resorption pit profiles between control and Charcot patient osteoclasts","volume":"10","author":"Petrova","year":"2013","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"10.1016\/j.jdiacomp.2017.11.004_bb0065","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1053\/j.jfas.2011.05.005","article-title":"Trabecular quality and cellular characteristics of normal, diabetic, and Charcot bone","volume":"50","author":"La Fontaine","year":"2011","journal-title":"J Foot Ankle Surg"},{"issue":"2","key":"10.1016\/j.jdiacomp.2017.11.004_bb0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/dme.12590","article-title":"Inflammatory and bone turnover markers in a cross-sectional and prospective study of acute Charcot osteoarthropathy","volume":"32","author":"Petrova","year":"2015","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.jdiacomp.2017.11.004_bb0075","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2337\/dc09-1141","article-title":"Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot","volume":"33","author":"Uccioli","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jdiacomp.2017.11.004_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8227(02)00097-9","article-title":"Biochemical and ultrasound tests for early diagnosis of active neuro-osteoarthropathy (NOA) of the diabetic foot","volume":"58","author":"Piaggesi","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.jdiacomp.2017.11.004_bb0085","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00125-008-0992-1","article-title":"Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand","volume":"51","author":"Mabilleau","year":"2008","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.jdiacomp.2017.11.004_bb0090","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/(SICI)1096-9136(199707)14:7<527::AID-DIA404>3.0.CO;2-Q","article-title":"Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy","volume":"14","author":"Gough","year":"1997","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.jdiacomp.2017.11.004_bb0095","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/17453674.2015.1033606","article-title":"Role of Wnt\/\u03b2-catenin and RANKL\/OPG in bone healing of diabetic Charcot arthropathy patients","volume":"86","author":"Folestad","year":"2015","journal-title":"Acta Orthop"},{"issue":"12","key":"10.1016\/j.jdiacomp.2017.11.004_bb0100","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: the OPG\/RANKL\/RANK system","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.jdiacomp.2017.11.004_bb0105","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jdiacomp.2017.11.004_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00223-003-0011-y","article-title":"Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease","volume":"74","author":"Sattler","year":"2004","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"10.1016\/j.jdiacomp.2017.11.004_bb0115","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2337\/dc10-2315","article-title":"Loss of RAGE defense: a cause of Charcot neuroarthropathy?","volume":"34","author":"Witzke","year":"2011","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.jdiacomp.2017.11.004_bb0120","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s00125-004-1477-5","article-title":"Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link?","volume":"47","author":"Jeffcoate","year":"2004","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.jdiacomp.2017.11.004_bb0125","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2337\/db10-1220","article-title":"The RANKL\/RANK\/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy","volume":"60","author":"Ndip","year":"2011","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jdiacomp.2017.11.004_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.fas.2012.12.007","article-title":"Effect of immobilization, off-loading and zoledronic acid on bone mineral density in patients with acute Charcot neuroarthropathy: a prospective randomized trial","volume":"19","author":"Pakarinen","year":"2013","journal-title":"Foot Ankle Surg"},{"issue":"5","key":"10.1016\/j.jdiacomp.2017.11.004_bb0135","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-2005-865600","article-title":"The AGE\/RAGE\/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT)","volume":"113","author":"Haslbeck","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"8","key":"10.1016\/j.jdiacomp.2017.11.004_bb0140","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2310\/JIM.0b013e318231db64","article-title":"Levels of soluble advanced glycation end product-receptors and other soluble serum markers as indicators of diabetic neuropathy in the foot","volume":"59","author":"El-Mesallamy","year":"2011","journal-title":"J Invest Med"},{"issue":"5","key":"10.1016\/j.jdiacomp.2017.11.004_bb0145","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jdiacomp.2011.06.006","article-title":"Sympathetic neuropathy in diabetes mellitus patients does not elicit Charcot osteoarthropathy","volume":"25","author":"Christensen","year":"2011","journal-title":"J Diabetes Complications"},{"issue":"7","key":"10.1016\/j.jdiacomp.2017.11.004_bb0150","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jdiacomp.2015.05.020","article-title":"Sarcopenia and body composition in diabetic Charcot osteoarthropathy","volume":"29","author":"Jansen","year":"2015","journal-title":"J Diabetes Complications"},{"issue":"6","key":"10.1016\/j.jdiacomp.2017.11.004_bb0155","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos Int"},{"issue":"Suppl. XXXVI","key":"10.1016\/j.jdiacomp.2017.11.004_bb0160","first-page":"101","article-title":"Charcot neuropathic osteoarthropathy, pro-inflammatory cytokines and bone turnover markers","volume":"94\u2013B","author":"Pearson","year":"2012","journal-title":"Orthop Proc"},{"key":"10.1016\/j.jdiacomp.2017.11.004_bb0165","first-page":"154","article-title":"Ultrasound and BMD measurements of the os calcis in normal Danish adults","volume":"4","author":"Zerahn","year":"1995","journal-title":"Eur J Musculoskel Res"},{"issue":"6","key":"10.1016\/j.jdiacomp.2017.11.004_bb0170","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1464-5491.2001.00511.x","article-title":"Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover","volume":"18","author":"Jirkovsk\u00e1","year":"2001","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.jdiacomp.2017.11.004_bb0175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/diacare.18.1.34","article-title":"Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy","volume":"18","author":"Young","year":"1995","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jdiacomp.2017.11.004_bb0180","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1460-9584.2000.00225.x","article-title":"Is diabetic Charcot foot related to lower limb osteopaenia?","volume":"6","author":"Clasen","year":"2000","journal-title":"Foot Ankle Surg"},{"key":"10.1016\/j.jdiacomp.2017.11.004_bb0185","doi-asserted-by":"crossref","first-page":"21117","DOI":"10.3402\/dfa.v4i0.21117","article-title":"An overview of the Charcot foot pathophysiology","volume":"4","author":"Kaynak","year":"2013","journal-title":"Diabet Foot Ankle"},{"issue":"2","key":"10.1016\/j.jdiacomp.2017.11.004_bb0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1148\/radiology.139.2.7220879","article-title":"Pathogenesis of the neurotrophic joint: neurotraumatic vs. neurovascular","volume":"139","author":"Brower","year":"1981","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.jdiacomp.2017.11.004_bb0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4239\/wjd.v2.i5.59","article-title":"Charcot osteoarthropathy in diabetes: a brief review with an emphasis on clinical practice","volume":"2","author":"Gouveri","year":"2011","journal-title":"World J Diabetes"},{"issue":"5","key":"10.1016\/j.jdiacomp.2017.11.004_bb0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","article-title":"Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies","volume":"27","author":"Ma","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jdiacomp.2017.11.004_bb0205","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-017-4026-z","article-title":"Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population","volume":"28","author":"J\u00f8rgensen","year":"2017","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.jdiacomp.2017.11.004_bb0210","first-page":"198","article-title":"Osteoprotegerin, RANK and RANKL are not modified by acute exercise in elite rugby players","volume":"52","author":"Banfi","year":"2012","journal-title":"J Sports Med Phys Fitness"},{"issue":"6","key":"10.1016\/j.jdiacomp.2017.11.004_bb0215","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bone.2009.07.088","article-title":"A 246-km continuous running race causes significant changes in bone metabolism","volume":"45","author":"Kerschan-Schindl","year":"2009","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.jdiacomp.2017.11.004_bb0220","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/230949901001800307","article-title":"Serum levels of bone turnover markers following total joint arthroplasty","volume":"18","author":"Kenanidis","year":"2010","journal-title":"J Orthop Surg (Hong Kong)"},{"issue":"3","key":"10.1016\/j.jdiacomp.2017.11.004_bb0225","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1464-5491.2010.02940.x","article-title":"Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in type 1 and type 2 diabetic patients","volume":"27","author":"Nybo","year":"2010","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.jdiacomp.2017.11.004_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0028-1085425","article-title":"Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy","volume":"117","author":"Terekeci","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"10","key":"10.1016\/j.jdiacomp.2017.11.004_bb0235","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2174\/138945007782151298","article-title":"Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes","volume":"8","author":"Yamagishi","year":"2007","journal-title":"Curr Drug Targets"},{"issue":"5","key":"10.1016\/j.jdiacomp.2017.11.004_bb0240","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1530\/EJE-06-0753","article-title":"The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study","volume":"156","author":"Stern","year":"2007","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872717311182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872717311182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T03:56:28Z","timestamp":1535255788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872717311182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1056872717311182"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.11.004","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}